Monthly Archives: September 2009

Director Kappos Speaks Out On The State Of The Patent Office

On September 15, 2009, Director David Kappos spoke at the National IPO Meeting in Chicago. (A link to the text is found below). I got calls almost immediately about various aspects of his comments. Like the blind folks trying to … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , | Leave a comment

Federal Circuit Reverses District Court in Prometheus v. Mayo

On September 16, 2009, the Federal Circuit reversed the holding of the district court that a process for monitoring and adjusting a method of medical treatment was unpatentable as attempting to claim non-statutory subject matter (Prometheus Labs., Inc. v. Mayo … Continue reading

Posted in Patenting Methods/Processes | Tagged , , , , , , | Leave a comment

Federal Circuit Reverses District Court's Finding that Generic Eloxatins do not Infringe Sanofi's Patent

In my June 22, 2009 post, I discussed the district court decision that found a claim to optically-pure oxaliplatin (U.S. Pat. No 5,338,874) not infringed by defendants who made it by processes other than the HPLC process disclosed in the … Continue reading

Posted in Prosecution History Estopped | Tagged , , , , , , , , , | Leave a comment

News Release from USPTO: USPTO ANNOUNCES SENIOR MANAGEMENT CHANGES

Commissioner for Patents John Doll to Retire; Robert L. Stoll Nominated as Successor, Margaret Focarino Named Deputy Commissioner The USPTO today announced significant changes among the senior management team of its Patent organization. After 35 years at the USPTO, Commissioner … Continue reading

Posted in USPTO Practice and Policy | Tagged | 1 Comment